BEYFORTUS™ (nirsevimab) is the first and only single-dose immunization designed for the prevention of RSV disease in newborns and infants, including those born healthy, at term or preterm, or with… Read More
CALGARY, AB — Timeless Capital Corp. (“Timeless”) (TSXV: TLC.P) and Renaissance BioScience Corp. (“Renaissance”) are pleased to announce that they have entered into an amalgamation agreement dated April 5, 2023 (the… Read More
Oral presentation by Dr. Jacqueline French to outline sustained monthly reduction in focal onset seizures during open-label extension of X-TOLE study Poster to present the trial design for Phase 3 X-ACKT clinical… Read More
Committee to increase collaboration on research between the two countries OTTAWA, ON — To solve the world’s most pressing challenges, we need the best and brightest working together. It is… Read More
Eagle Ridge Hospital became the first of Fraser Health Authority’s twelve hospitals to go LIVE with MEDITECH Expanse on April 15. April 21, 2023 | Corporate Expanse Updates Press Releases Signings… Read More
